Joseph S Zakrzewski Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Joseph S Zakrzewski.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Joseph S Zakrzewski. Joseph S Zakrzewski is a in AMARIN CORP PLC\UK ($AMRN) and a Director in AMARIN CORP PLC\UK ($AMRN) and a Director in SANGAMO THERAPEUTICS, INC ($SGMO) and a Director in INSULET CORP ($PODD) and a Director in ACCELERON PHARMA INC ($XLRN).

Over the past year Joseph S Zakrzewski has been an insider in 3 companies. The total value of shares held by Joseph S Zakrzewski in these companies amounts to $2,182,321.

Joseph S Zakrzewski Director
ACCELERON PHARMA INC
AMARIN CORP PLC\UK
Director
INSULET CORP
Director
SANGAMO THERAPEUTICS, INC
$ 2182321 The total value of shares held by Joseph S Zakrzewski
Insider Rank

Joseph S Zakrzewski ranks 10,472 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: C/O DOV PHARAMACEUTICALS, INC. 150 PIERCE STREET SOMERSET 08873 NJ

Companies in which Joseph S Zakrzewski is an Insider

ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Joseph S Zakrzewski: Director
Holdings: 32,877 shares
Current Value: $780,500
Latest Transaction: Jan 24 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 0x
Shares Bought: 32,877
Shares Sold: 0
Share Difference: +32,877
Value Difference: -$365,000

AMARIN CORP PLC\UK

Trading Symbol: AMRN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph S Zakrzewski:
Holdings: 384,547 shares
Current Value: $1,276,696
Latest Transaction: Jul 15 2020
$AMRN Market Capitalization: $901.76M
$AMRN Previous Close: $3.32

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 10x
Shares Bought: 1,280,625
Shares Sold: 1,280,625
Share Difference: 0
Value Difference: +$14,546,479

INSULET CORP

Trading Symbol: PODD
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Joseph S Zakrzewski: Director
Holdings: 30,558 shares
Current Value: $1,314,911
Latest Transaction: May 18 2017
$PODD Market Capitalization: $2.43B
$PODD Previous Close: $43.03

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 3x
Shares Bought: 46,519
Shares Sold: 40,000
Share Difference: +6,519
Value Difference: +$1,353,006

SANGAMO THERAPEUTICS, INC

Trading Symbol: SGMO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Joseph S Zakrzewski: Director
Holdings: 32,500 shares
Current Value: $125,125
Latest Transaction: May 20 2020
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 32,500
Shares Sold: 0
Share Difference: +32,500
Value Difference: -$147,950

Latest Insider Trading Transactions of Joseph S Zakrzewski

Sentiment: All, XLRN, AMRN, PODD, SGMO

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 15 2020AMRNAMARIN CORP PLC\UKZakrzewski Joseph SOption ExerciseA0.0027,191027,191
Jul 15 2020AMRNAMARIN CORP PLC\UKZakrzewski Joseph SOption ExerciseA6.6234,805230,40934,805
Jul 15 2020AMRNAMARIN CORP PLC\UKZakrzewski Joseph SOption ExerciseA0.0027,191027,191
Jul 15 2020AMRNAMARIN CORP PLC\UKZakrzewski Joseph SOption ExerciseA6.6234,805230,40934,805
May 20 2020SGMOSANGAMO THERAPEUTI ...Zakrzewski Joseph SDirectorOption ExerciseA10.4615,000156,90015,000
May 20 2020SGMOSANGAMO THERAPEUTI ...Zakrzewski Joseph SDirectorGrantA0.002,500032,50030 K to 32.5 K (+8.33 %)
Mar 19 2020SGMOSANGAMO THERAPEUTI ...Zakrzewski Joseph SDirectorBuyP4.995,00024,95030,00025 K to 30 K (+20.00 %)

View all Joseph S Zakrzewski insider transactions.